Texas Oncology Gulf Coast is a clinical research site located in Houston, Texas, United States 77024.
Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.
Texas Oncology Gulf Coast has participated in 21 clinical trials with 18 currently active.
Therapeutic areas: Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms, Non-small Cell Lung Cancer.
Sponsors: Merck Sharp & Dohme LLC, Effector Therapeutics, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Texas · View every site in Houston
Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology Gulf Coast has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology Gulf Coast has 21 clinical trials on record, with 18 currently active. Their work covers Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms, Non-small Cell Lung Cancer.
Texas Oncology Gulf Coast has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.